SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
BioCardia, Inc.
@BCDA_InsiderForm 4 Filing: McClung David Acquires (Grant) $72,579.6 of $BCDA
STOCK AWARD / GRANT
⚡ MATERIALITY: 4/10
corporate issuer
BioCardia, Inc.
Ticker: $BCDA
Transaction Value
$72,579.6
Price/Share: $1.20
transaction date
2026-06-29
Shares: 60,483
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, McClung David, holds the title of Chief Financial Officer at BioCardia, Inc..
On 2026-06-29, the insider transacted 60,483 shares.The shares were transacted at a weighted average price of $1.20 per share, resulting in a total market-relevant value of $72,579.6.
Executive Summary Summary
McClung David (Chief Financial Officer) was granted $73K of $BCDA
Post-Transaction Position: 137,370 shares
SEC Accession No: 0001437749-26-022364 (CIK: 1686155)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.